4
Changes in Ownership
Oruka Therapeutics, Inc. Filed Acc 0001209191-16-142259
S.V.P., General Counsel sold 1,185 shares at $2.89 ($3,425)
From the SEC's structured data for this filing
Trades in this filing
Ozeroff Christopher David · S.V.P., General Counsel
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2016-09-20 | Sale : show line 1 in the form | −1,185 | $2.89 | $3,425 | 18,400 | D |
| Open-market sales · 1,185 sh · avg $2.89 · $3,425 | ||||||
Loading xslF345X03/doc4.xml…